Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FMC CORPFMC · Entity 4704 | Director | July 16, 2026 | July 17, 2026 |
| QUAKER CHEMICAL CORPKWR · Entity 4278 | Director | February 10, 2026 | February 12, 2026 |
| ROGERS CORPROG · Entity 4438 | Director | May 09, 2019 | May 13, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FMC CORP
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,820.191 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 11 · Balance 28,820.191 F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.
QUAKER CHEMICAL CORP
Report date February 10, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,010 |
Ending reported balance
After 2026-02-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-10 · Exercise / conversion · Acquired 8,212 · Balance 84,886 Row 2 · 2026-02-10 · Tax withholding · Disposed 6,876 · Balance 78,010 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.64 · Expires 2027-03-30 | Direct | 0 |
Reported balance
After 2026-02-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-10 · Exercise / conversion · Disposed 8,212 · Balance 0 F1: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The options for this grant vested in three annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023.
ROGERS CORP
Report date May 09, 2019 · Filed May 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital (Common) StockSEC Table I · non-derivative | Direct | 17,350 |
Reported balance
After 2019-05-09 transaction · row 1
1 source rowRow 1 · 2019-05-09 · Grant · Acquired 850 · Balance 17,350 F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Arcadium Lithium plc
Report date March 06, 2025 · Filed March 06, 2025
Section 16 reporting ended · disclosed 2025-03-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2025-03-06 · Disposition to issuer · Disposed 92,061 · Balance 0 F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration"). |
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-03-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2025-03-06 · Disposition to issuer · Disposed 40,786 · Balance 0 F2: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock of Aracdium Lithium plc ("Arcadium") disposed of pursuant to the Transaction Agreement, dated October 9, 2024, by and among Arcadium, Rio Tinto Western Holdings Limited ("Parent") and Rio Tinto BM Subsidiary Limited ("Buyers") (the "Transaction Agreement"). Pursuant to the Transaction Agreement, at the effective time of the transaction contemplated thereby (the "Effective Time"), each share of Arcadium common stock held by the reporting person was converted automatically into the right to receive $5.85 per share in cash (the "Consideration").
F2: Pursuant to the Transaction Agreement, at the Effective Time, each award of Arcadium restricted stock units held by the reporting person was canceled in exchange for the right to receive the Consideration in respect of each share of Arcadium common stock subject to such restricted stock unit award as of immediately prior to the Effective Time.
Livent Corp.
Report date January 04, 2024 · Filed January 08, 2024
Section 16 reporting ended · disclosed 2024-01-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2024-01-04 · Disposition to issuer · Disposed 34,475 · Balance 0 F1: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")). |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-01-04 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2024-01-04 · Disposition to issuer · Disposed 32,875 · Balance 0 F2: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")).
F2: Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 20, 2020 Filed Jul 22, 2020 21:38 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 2,788 | $198.08 | $552,247.04 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,125 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 28, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.55 to $198.50, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 21:38 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 2,650 | $196.90 | $521,785.00 |
DisclosureSEC source: 0001209191-20-043356 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,913 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on May 28, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.54 to $197.54, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,501 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · derivative · entry 9 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Common Stock · 13,501 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options for this grant vest in three annual installments: 6,751 shares on February 26, 2019; 6,750 shares on February 26, 2020; and 6,750 shares on February 26, 2021. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,241 | $0.00 Strike: $134.60 | $0.00 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · derivative · entry 8 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,241 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options for this grant vested in three annual installments: 7,081 shares on February 27, 2018; 7,080 shares on February 27, 2019; and 7,080 shares on February 27, 2020. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 10,293 | $199.03 | $2,048,615.79 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,563 Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 13,501 | $151.75 | $2,048,776.75 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 14,364 | $199.03 | $2,858,866.92 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,355 Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 21,241 | $134.60 | $2,859,038.60 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 178 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 2,674 Read SEC document |
| May 18, 2020 Filed Jul 17, 2020 20:15 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 712 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-042811 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,478 Read SEC document |
| May 01, 2020 Filed May 5, 2020 16:19 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 15,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-015361 · form4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,114 Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:34 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 24,638 | $0.00 Strike: $136.64 | $0.00 |
DisclosureSEC source: 0001209191-20-022125 · doc4.xml · derivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,628 Underlying: Common Stock · 24,638 shares Expires 2027-03-30 F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2020-2022 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 30, 2023 and the stock options are exercisable in three consecutive annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:34 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 5,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022125 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,190 F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2020-2022 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on March 30, 2023 and the stock options are exercisable in three consecutive annual installments: 8,213 shares on March 30, 2021; 8,213 shares on March 30, 2022; and 8,212 shares on March 30, 2023. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 21:12 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 1,899 | $163.31 | $310,125.69 |
DisclosureSEC source: 0001209191-20-014429 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,543 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 27, 2017 under the Company's 2016 Long-Term Performance Incentive Plan. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:17 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 8,200 | $180.26 | $1,478,099.20 |
DisclosureSEC source: 0001209191-20-009171 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,442 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. There will be no further sales under this Plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $181.00, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 600 | $180.01 | $108,004.02 |
DisclosureSEC source: 0001209191-20-007527 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,642 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.04, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| February 05, 2020 Filed Feb 7, 2020 21:30 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,200 | $180.08 | $216,092.04 |
DisclosureSEC source: 0001209191-20-007527 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,242 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.32, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| December 16, 2019 Filed Dec 31, 2019 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 2,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-062239 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,442 Read SEC document |
| December 13, 2019 Filed Dec 31, 2019 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-062239 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 2,496 Read SEC document |
| December 13, 2019 Filed Dec 31, 2019 21:06 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 740 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-062239 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,817 Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,834 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · derivative · entry 14 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,834 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options for this grant vested in three annual installments: 11,289 shares on February 23, 2017; 11,289 shares on February 23, 2018; and 11,289 shares on February 23, 2019. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,697 | $159.82 | $271,214.54 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 10 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,557 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.55 to $160.18, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (8) to this Form 4. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,598 | $158.69 | $253,586.62 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 9 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,254 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.27 to $159.10, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (7) to this Form 4. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 539 | $157.48 | $84,881.72 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 8 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,852 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.05 to $158.02, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Read SEC document |
| September 06, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 3,834 | $72.12 | $276,508.08 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 7 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 18,744 | $0.00 Strike: $72.12 | $0.00 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · derivative · entry 13 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,834 Underlying: Common Stock · 18,744 shares Expires 2023-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The options for this grant vested in three annual installments: 11,289 shares on February 23, 2017; 11,289 shares on February 23, 2018; and 11,289 shares on February 23, 2019. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 28 | $162.07 | $4,537.96 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,557 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,857 | $161.43 | $299,778.48 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,585 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.95 to $161.89, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 2,072 | $160.28 | $332,094.36 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,442 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.88 to $160.79, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 6,343 | $159.21 | $1,009,877.91 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,514 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.81 to $159.77, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 8,444 | $158.49 | $1,338,317.43 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,857 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 30, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.80 to $158.795, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:22 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 18,744 | $72.12 | $1,351,817.28 |
DisclosureSEC source: 0001209191-19-048895 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:27 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 21,193 | $0.00 Strike: $154.92 | $0.00 |
DisclosureSEC source: 0001209191-19-046545 · doc4.xml · derivative · entry 4 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,193 Underlying: Common Stock · 21,193 shares Expires 2026-02-25 F1 · derivative.exercise_date: This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 7,065 shares on February 25, 2020; 7,064 shares on February 25, 2021; and 7,064 shares on February 25, 2022. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:27 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 4,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046545 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,557 F1 · shares: This award represents time-based restricted stock and stock options granted to reporting person for the 2019-2021 Performance Period under the Company's 2016 Long-Term Performance Incentive Plan. The restricted stock vests on February 25, 2022 and the stock options are exercisable in three consecutive annual installments: 7,065 shares on February 25, 2020; 7,064 shares on February 25, 2021; and 7,064 shares on February 25, 2022. Read SEC document |
| May 09, 2019 Filed May 13, 2019 19:36 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-007820 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,350 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 9, 2019 award of deferred stock units. Read SEC document |
| May 01, 2019 Filed May 3, 2019 15:12 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 8,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-017170 · form4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,434 Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 21:20 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 3,221 | $212.05 | $683,013.05 |
DisclosureSEC source: 0001209191-19-013513 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,226 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 23, 2016 under the Company's 2011 Long-Term Performance Incentive Plan. Read SEC document |
| October 15, 2018 Filed Oct 15, 2018 23:09 UTC | Livent Corp. LTHM · Entity 95365 | PurchaseCommon Stock | 26,000 | $17.00 | $442,000.00 |
DisclosureSEC source: 0000950103-18-012047 · dp96869_4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,959 F2 · shares: Reflects the number of shares of common stock purchased under the Issuer's Directed Share Program in connection with the Issuer's initial public offering of common stock. Read SEC document |
| October 15, 2018 Filed Oct 15, 2018 23:09 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 2,959 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-18-012047 · dp96869_4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 F1 · shares: Reflects the grant of restricted stock units under the Issuer's Incentive Compensation and Stock Plan (the "Plan"), which are scheduled to vest 100% on the date of the Issuer's next annual meeting of stockholders following the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. Read SEC document |
| October 04, 2018 Filed Dec 31, 2018 21:13 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-064399 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 2,311 Read SEC document |
| October 04, 2018 Filed Dec 31, 2018 21:13 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 588 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-064399 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,447 Read SEC document |
| May 03, 2018 Filed May 7, 2018 18:36 UTC | ROGERS CORP ROG · Entity 4438 | GrantCapital (Common) Stock | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-008790 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 F1 · shares: Represents shares of Rogers Corporation Capital (Common) Stock receivable pursuant to the May 3, 2018 award of deferred stock units. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:36 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,965 | $0.00 Strike: $87.30 | $0.00 |
DisclosureSEC source: 0001209191-18-016480 · doc4.xml · derivative · entry 6 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,965 shares Expires 2022-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options for this grant vested in three annual installments: 5,966 shares on February 25, 2016; 5,966 shares on February 25, 2017; and 5,965 shares on February 25, 2018. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:36 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 4,630 | $153.00 | $708,390.00 |
DisclosureSEC source: 0001209191-18-016480 · doc4.xml · nonDerivative · entry 3 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,035 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:36 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Exercise / conversionCommon Stock | 5,965 | $87.30 | $520,744.50 |
DisclosureSEC source: 0001209191-18-016480 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:36 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | SaleCommon Stock | 1,250 | $160.13 | $200,160.00 |
DisclosureSEC source: 0001209191-18-016480 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,700 F1 · kind: The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 30, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.10 to $161.05, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:52 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantEmployee Stock Option (right to buy) · Derivative | 20,251 | $0.00 Strike: $151.75 | $0.00 |
DisclosureSEC source: 0001209191-18-013964 · doc4.xml · derivative · entry 5 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,251 Underlying: Common Stock · 20,251 shares Expires 2025-02-26 F3 · derivative.exercise_date: Stock options granted to reporting person under the Company's 2016 Long-Term Performance Incentive Plan and exercisable in three consecutive annual installments: 6,751 shares on February 26, 2019; 6,750 shares on February 26, 2020; and 6,750 shares on February 26, 2021. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:52 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GrantCommon Stock | 4,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-013964 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,950 Read SEC document |
| February 25, 2018 Filed Feb 27, 2018 21:52 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | Tax withholdingCommon Stock | 2,182 | $151.28 | $330,092.96 |
DisclosureSEC source: 0001209191-18-013964 · doc4.xml · nonDerivative · entry 1 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,843 F1 · shares: Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on February 25, 2015 under the Company's 2011 Long-Term Performance Incentive Plan. Read SEC document |
| July 24, 2017 Filed Dec 21, 2017 21:52 UTC | QUAKER CHEMICAL CORP KWR · Entity 4278 | GiftCommon Stock | 184 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066815 · doc4.xml · nonDerivative · entry 2 BARRY MICHAEL F · CIK 0001238141 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 2,164 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.